Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease
Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation
研究概览
地位
条件
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Mia Sommer, MHsc
- 电话号码:0045 9766 0896
- 邮箱:m.sommer@rn.dk
学习地点
-
-
-
Aalborg、丹麦、9000
- 招聘中
- Aalborg University Hospital, Department of Hematology
-
接触:
- Mia Sommer, MHSc
- 电话号码:+45 9766 0896
- 邮箱:m.sommer@rn.dk
-
接触:
- Lise T Elkjær
- 电话号码:+45 9766 3871
- 邮箱:lit@rn.dk
-
首席研究员:
- Mia Sommer, MHSc
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease
- patients followed before or after 1. line treatment
- patients in stable phase > 6 months after 1. line treatment
- the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment
Exclusion Criteria:
- Health conditions which demands close medical monitoring
- conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability)
- lack of capability to fill out electronic questionnaires
- poor self-care and/or compliance
学习计划
研究是如何设计的?
设计细节
- 观测模型:仅案例
- 时间观点:预期
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Health-Related Quality of Life (HRQoL) - General
大体时间:HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is SF-36. SF-36 is a generic questionnaire which can be used to assess HRQoL in the general public. |
HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
Health-Related Quality of Life (HRQoL) - Disease specific
大体时间:HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is EORTC C30 QLQ. EORTC C30 QLQ is a disease specific questionnaire which can be used to assess HRQoL in patients diagnosed with cancer |
HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Symptoms of depression and anxiety
大体时间:Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
Data on symptoms of depression and anxiety will be collected before and after each consultation using an international validated questionnaire. The questionnaire which will be used is: Hospital Depression and Anxiety Scale (HADS) |
Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
Symptoms of hematological disease
大体时间:Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
Data on symptoms of disease will be collected before each consultation using an international validated questionnaire. The questionnaire which will be used is: Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) |
Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
合作者和调查者
调查人员
- 首席研究员:Mia Sommer, MHSc、Aalborg University Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- TVO
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.